<?xml version="1.0" encoding="UTF-8"?>
<ref id="B90">
 <label>90.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pizzorno</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Terrier</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Nicolas de Lamballerie</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Julien</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Padey</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Traversier</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures</article-title>. 
  <source>Front Immunol</source>. (
  <year>2019</year>) 
  <volume>10</volume>:
  <fpage>60</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fimmu.2019.00060</pub-id>
  <?supplied-pmid 30761132?>
  <pub-id pub-id-type="pmid">30761132</pub-id>
 </mixed-citation>
</ref>
